Kintara Therapeutics: Q2 Earnings Insights

Comments
Loading...

Kintara Therapeutics KTRA reported its Q2 earnings results on Friday, February 11, 2022 at 08:15 AM.

Here's what investors need to know about the announcement.

Earnings

Kintara Therapeutics beat estimated earnings by 25.0%, reporting an EPS of $-0.12 versus an estimate of $-0.16.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11, which was followed by a 3.73% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!